MENU
+Compare
IBO
Stock ticker: ASE
AS OF
Jun 27 closing price
Price
$0.75
Change
-$0.17 (-18.48%)
Capitalization
9.09M

IBO Impact BioMedical Inc. Forecast, Technical & Fundamental Analysis

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases... Show more

IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IBO with price predictions
Jun 27, 2025

IBO's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for IBO moved out of overbought territory on June 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 instances where the indicator moved out of the overbought zone. In of the 2 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IBO broke above its upper Bollinger Band on June 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IBO entered a downward trend on June 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 9 cases where IBO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 23, 2025. You may want to consider a long position or call options on IBO as a result. In of 12 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IBO just turned positive on June 23, 2025. Looking at past instances where IBO's MACD turned positive, the stock continued to rise in of 3 cases over the following month. The odds of a continued upward trend are .

IBO moved above its 50-day moving average on June 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IBO crossed bullishly above the 50-day moving average on June 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.402) is normal, around the industry mean (16.366). P/E Ratio (8.097) is within average values for comparable stocks, (58.189). IBO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IBO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IBO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTL20.350.60
+3.04%
Castle Biosciences
LII567.492.98
+0.53%
Lennox International
ALG217.10-2.35
-1.07%
Alamo Group
BCLI1.06-0.03
-2.75%
Brainstorm Cell Therapeutics
OM19.07-1.06
-5.27%
Outset Medical Inc

IBO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IBO has been loosely correlated with ITOS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IBO jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBO
1D Price
Change %
IBO100%
-18.26%
ITOS - IBO
44%
Loosely correlated
-0.70%
BMRN - IBO
42%
Loosely correlated
+1.98%
NCNA - IBO
29%
Poorly correlated
N/A
APVO - IBO
27%
Poorly correlated
-4.64%
ADAG - IBO
24%
Poorly correlated
-1.03%
More